Compare ALKS & EMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALKS | EMN |
|---|---|---|
| Founded | 1987 | 1920 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.7B | 7.7B |
| IPO Year | 2012 | 1996 |
| Metric | ALKS | EMN |
|---|---|---|
| Price | $52.35 | $68.99 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 13 |
| Target Price | $43.43 | ★ $79.31 |
| AVG Volume (30 Days) | ★ 2.3M | 1.2M |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 4.77% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.93 |
| Revenue | $1,475,899,000.00 | ★ $8,752,000,000.00 |
| Revenue This Year | $24.26 | $3.06 |
| Revenue Next Year | $4.47 | $3.47 |
| P/E Ratio | ★ N/A | $73.20 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $25.17 | $56.11 |
| 52 Week High | $55.67 | $83.47 |
| Indicator | ALKS | EMN |
|---|---|---|
| Relative Strength Index (RSI) | 59.70 | 49.73 |
| Support Level | $27.78 | $66.31 |
| Resistance Level | $55.67 | $71.02 |
| Average True Range (ATR) | 1.71 | 1.85 |
| MACD | -0.62 | 0.28 |
| Stochastic Oscillator | 33.55 | 77.10 |
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
Established in 1920 to produce chemicals for Eastman Kodak, Eastman Chemical has grown into a global specialty chemical company with manufacturing sites around the world. The company generates the majority of its sales outside of the United States, with a strong presence in Asian markets. During the past several years, Eastman has sold noncore businesses, choosing to focus on higher-margin specialty product offerings.